Comparison of the classic Glucksberg criteria and the IBMTR Severity Index for grading acute graft-versus-host disease following HLA-identical sibling stem cell transplantation

Bone Marrow Transplantation

Volumn 24, Issue 3, 1999, Pages 283-287

  Martino, R ^a   Romero, P ^a   Subira M ^a   Bellido, M ^a   Altes A ^a   Sureda, A ^a   Brunet, S ^a   Badell, I ^a   Cubells, J ^a   Sierra, J ^a  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Grading; Graft versus host disease; Stem cell transplantation

Indexed keywords

ACUTE LEUKEMIA; ADOLESCENT; ADULT; APLASTIC ANEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CHILD; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; DISEASE SEVERITY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE MYELOMA; MYELODYSPLASTIC SYNDROME; PREDICTION; PRIORITY JOURNAL; REGISTER; SCHOOL CHILD; STEM CELL TRANSPLANTATION;

EID: 0032812345     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701899     Document Type: Article

References (14)

1. Weisdorf D, Haake R, Blazar B et al. Treatment of moderate/severe acute GVHD after allogeneic BMT: an analysis of clinical risk features and outcome. Blood 1990; 75: 1024-1030.
2. Lazarus HM, Vogelsang GB, Rowe JM. Prevention and treatment of acute GVHD: the old and the new. A report from the ECOG. Bone Marrow Transplant 1997; 19: 577-600.
3. Martin PJ, Schoch G, Fisher L et al. A retrospective analysis of therapy for acute GVHD: initial treatment. Blood 1990; 76: 1464-1472.
4. Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA matched sibling donors. Transplantation 1974; 18: 295-304.
5. Thomas ED, Storb R, Clift RA et al. Bone marrow transplantation. New Engl J Med 1975; 292: 895-902.
6. Rowlings PA, Przepiorka D, Klein JP et al. IBMTR Severity Index for grading graft-versus-host disease: retrospective comparison with Glucksberg grade. Br J Haematol 1997; 97: 855-864.
7. + cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase. Bone Marrow Transplant 1997; 20: 945-952.
8. + cells from peripheral blood: experience of 62 cases using immunoadsorption or immunomagnetic technique. Bone Marrow Transplant 1998; 22: 519-525.
9. Andersen PK, Borgan O, Gill RD, Keiding N. Statistical Models Based on Counting Processes. Springer: New York, 1993.
10. Przepiorka D, Weisdorf D, Martin P et al. Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995; 15: 825-828.
11. Gratwohl A, Hermans J, Apperley J et al. Acute graft-versus-host disease: grade and outcome in patients with chronic myelogenous leukemia. Blood 1995; 86: 813-818.
12. Martin P, Schoch G, Gooley T et al. Methods of assessment of graft-versus-host disease. Blood 1998; 92: 3479-3480.
13. Van Lint MT, Uderzo C, Locasciulli A et al. Early treatment of acute graft-versus-host disease with high- or low-dose 6-methylprednisolone: a multicenter randomized trial from the Italian Group for Bone Marrow Transplantation. Blood 1998; 92: 2288-2293.
14. Martin P, Nash R, Sanders J et al. Reproducibility in retrospective grading of acute graft-versus-host disease after allogeneic marrow transplantation. Bone Marrow Transplant 1998; 21: 273-279.